Table 3.
LncRNA-mediated ceRNA network is associated with patient's clinic-pathological features and outcomes.
| LncRNA mediated ceRNA network | Tumor size | Grade | TNM | Prognosis | Survival rate | Ref. |
|---|---|---|---|---|---|---|
| XIST/miR-124/AR | ✓ | [35] | ||||
| XIST/miR-139–5p/Wnt1 | ✓ | ✓ | ✓ | ✓ | [38] | |
| MALAT1/miR-34a/CCND1 | ✓ | [41] | ||||
| BCAR4/miR-644a/TLX1 | ✓ | [60] | ||||
| CASC9/miR-497–5p/FZD6 | ✓ | ✓ | ✓ | [64] | ||
| CASC9/miR-758–3p/TGFβ2 | ✓ | [66] | ||||
| DANCR/miR-149/MSI2 | ✓ | ✓ | [70] | |||
| PCAT6/miR-513a | ✓ | [79] | ||||
| MAGI2-AS3/miR-15b-5p/CCDC19 | ✓ | [85] | ||||
| MAGI2-AS3/miR-31–5p/TNS1 | ✓ | [54] | ||||
| LINC00319/miR-4492/ROMO1 | ✓ | [116] | ||||
| LINC00641/miR-197–3p/KLF10 | ✓ | [117] | ||||
| SNHG3/miR-515–5p/GINS2 | ✓ | [50] | ||||
| SNHG7/miR-2682–5p/ELK1 | ✓ | [55] | ||||
| HAND2-AS1/miR-146/RARB | ✓ | [118] | ||||
| ZEB1-AS1/miR-200b/FSCN1 | ✓ | ✓ | ✓ | [97] | ||
| SOX2OT/miR-200c/SOX2 | ✓ | ✓ | ✓ | [100] | ||
| RNF144A-AS1/miR-455–5p/SOX11 | ✓ | [120] | ||||
| lncARSR/miR-129–5p/SOX4 | ✓ | ✓ | [121] | |||
| miR143HG/miR-1275/AXIN2 | ✓ | [125] | ||||
| PLAC2/miR-663/TGF-β1 | ✓ | [127] | ||||
| TINCR/miR-7/mTOR | ✓ | ✓ | [131] | |||
| TMPO-AS1/miR-98–5p/EBF1 | ✓ | [132] | ||||
| GAS6-AS2/miR-298/CDK9 | ✓ | ✓ | [134] | |||
| ARAP1-AS1/miR-4735–3p/NOTCH2 | ✓ | [135] | ||||
| PlncRNA-1/miR-136/smad3 | ✓ | [136] | ||||
| CALML3-AS1/miR-4316/ZBTB2 | ✓ | ✓ | [137] | |||
| SLCO4A1-AS1/miR-335–5p/OCT4 | ✓ | ✓ | [138] | |||
| ZNFX1-AS1/miR-193a-3p/SDC1 | ✓ | ✓ | [143] | |||
| GAS5/MiR-21/PTEN | ✓ | [144] |